Annual Cash & Cash Equivalents
$574.96 M
-$57.18 M-9.04%
31 December 2023
Summary:
Maravai LifeSciences Holdings annual cash & cash equivalents is currently $574.96 million, with the most recent change of -$57.18 million (-9.04%) on 31 December 2023. During the last 3 years, it has risen by +$338.78 million (+143.44%). MRVI annual cash & cash equivalents is now -9.04% below its all-time high of $632.14 million, reached on 31 December 2022.MRVI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$578.16 M
+$4.99 M+0.87%
30 September 2024
Summary:
Maravai LifeSciences Holdings quarterly cash and cash equivalents is currently $578.16 million, with the most recent change of +$4.99 million (+0.87%) on 30 September 2024. Over the past year, it has dropped by -$1.45 million (-0.25%). MRVI quarterly cash and cash equivalents is now -8.54% below its all-time high of $632.14 million, reached on 31 December 2022.MRVI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRVI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | -0.3% |
| 3 y3 years | +143.4% | +5.5% |
| 5 y5 years | +2529.5% | - |
MRVI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.0% | +143.4% | -8.5% | +34.0% |
| 5 y | 5 years | -9.0% | +2529.5% | -8.5% | +2240.7% |
| alltime | all time | -9.0% | +2529.5% | -8.5% | +2240.7% |
Maravai LifeSciences Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $578.16 M(+0.9%) |
| June 2024 | - | $573.17 M(+2.0%) |
| Mar 2024 | - | $561.69 M(-2.3%) |
| Dec 2023 | $574.96 M(-9.0%) | $574.96 M(-0.8%) |
| Sept 2023 | - | $579.61 M(-0.1%) |
| June 2023 | - | $580.18 M(-7.7%) |
| Mar 2023 | - | $628.27 M(-0.6%) |
| Dec 2022 | $632.14 M | $632.14 M(+2.4%) |
| Sept 2022 | - | $617.45 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $550.68 M(+27.6%) |
| Mar 2022 | - | $431.47 M(-21.7%) |
| Dec 2021 | $551.27 M(+133.4%) | $551.27 M(+0.6%) |
| Sept 2021 | - | $547.90 M(+46.2%) |
| June 2021 | - | $374.71 M(+51.3%) |
| Mar 2021 | - | $247.68 M(+4.9%) |
| Dec 2020 | $236.18 M(+856.2%) | $236.18 M(+550.4%) |
| Sept 2020 | - | $36.31 M(+47.0%) |
| Dec 2019 | $24.70 M(+13.0%) | $24.70 M |
| Dec 2018 | $21.87 M | - |
FAQ
- What is Maravai LifeSciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual cash & cash equivalents year-on-year change?
- What is Maravai LifeSciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
What is Maravai LifeSciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of MRVI is $574.96 M
What is the all time high annual cash & cash equivalents for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual cash & cash equivalents is $632.14 M
What is Maravai LifeSciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, MRVI annual cash & cash equivalents has changed by -$57.18 M (-9.04%)
What is Maravai LifeSciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MRVI is $578.16 M
What is the all time high quarterly cash and cash equivalents for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly cash and cash equivalents is $632.14 M
What is Maravai LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, MRVI quarterly cash and cash equivalents has changed by -$1.45 M (-0.25%)